Jill M. Quigley

Companies

• Chemomab Therapeutics Ltd.Board member Jun 21, 2022 to now¹
• Terns Pharmaceuticals, Inc.Board member Feb 4, 2021 to now²
• Terns Pharmaceuticals, Inc.Sr. Advisor & Strategy Officer Nov 17, 2023 to Jan 25, 2024³
• Passage BIO, Inc.Chief operating officer Feb 27, 2020 to Dec 10, 2021⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PBPassage BIO, Inc. PASG372,362 shares⁵$1.3M at $3.44Dec 10, 2021
• TPTerns Pharmaceuticals, Inc.0 shares⁶Nov 4, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Nov 4, 2025Sold 24,520 shares at $18.00 of Terns Pharmaceuticals, Inc.⁶
• Nov 4, 2025Exercised options 24,520 shares at $9.24 of Terns Pharmaceuticals, Inc.⁶
• Jan 6, 2025Sold 8,760 shares at $5.79 of Terns Pharmaceuticals, Inc.⁷
• Jan 2, 2025Sold 6,240 shares at $5.72 of Terns Pharmaceuticals, Inc.⁷
• Sep 9, 2024Sold 17,235 shares at $10.00 of Terns Pharmaceuticals, Inc.⁸
• Sep 9, 2024Exercised options 17,235 shares at $1.82 of Terns Pharmaceuticals, Inc.⁸
• Aug 2, 2024Sold 8,857 shares at $7.50 of Terns Pharmaceuticals, Inc.⁹
• Aug 1, 2024Sold 6,143 shares at $7.68 of Terns Pharmaceuticals, Inc.⁹
• Jul 16, 2024Sold 400 shares at $10.00 of Terns Pharmaceuticals, Inc.¹⁰
• Jul 16, 2024Exercised options 400 shares at $1.82 of Terns Pharmaceuticals, Inc.¹⁰
• Jul 15, 2024Sold 14,365 shares at $10.00 of Terns Pharmaceuticals, Inc.¹⁰
• Jul 15, 2024Exercised options 14,365 shares at $1.82 of Terns Pharmaceuticals, Inc.¹⁰
• Jan 23, 2024Granted 15,000 shares of Terns Pharmaceuticals, Inc.¹¹
• Nov 15, 2023Granted 15,000 shares of Terns Pharmaceuticals, Inc.¹²
• Dec 8, 2021Exercised options 71,975 shares at $0.23 of Passage BIO, Inc.⁵